%0 Journal Article
%T The Role of Pediatric Pharmacists in the Prevention and Treatment of Congenital Syphilis.
%A Barnes T
%A Girotto JE
%J J Pediatr Pharmacol Ther
%V 29
%N 4
%D 2024 Aug
%M 39144389
暂无%R 10.5863/1551-6776-29.4.429
%X In recent years, rates of syphilis in adults have been on the rise resulting in an increase in the number of neonates born with congenital syphilis. National organizations including the Centers for Disease Control and Prevention as well as The US Preventative Services Task Force recommend routine testing of pregnant persons to identify and provide maternal syphilis treatment prior to delivery. Significant variability exists between states for these screenings, resulting in some pregnant persons not being diagnosed prior to delivery. The Pediatric Pharmacy Association (PPA) believes that pharmacists, along with other health care providers can help by ensuring optimal syphilis testing and treatment pathways for pregnant individuals and newborns are included in their workplaces. PPA also supports pharmacists working to increase treatment compliance by providing medication education and counseling regarding optimal treatment of syphilis infections, as well as work with state and local governments to standardize treatment recommendations.